Brief: Allarity Therapeutics Announces Board Authorization Of $5 Million Share Repurchase Program
03/03/2025 14:44
March 3 (Reuters) - Allarity Therapeutics Inc ALLR.O: ALLARITY THERAPEUTICS ANNOUNCES BOARD AUTHORIZATION OF $5 MILLION SHARE REPURCHASE PROGRAM Source text: ID:nGNX8BjMyM Further company coverage: ALLR.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic